$NVAX It's time for a little explanation To say NVAX at $200 is too high because companies like $MRNA are not there. It's no sense. If want compares the stock value of 2 companies, take the market cap of the first company, divided by the number of shares outstanding. Do the same for the second company. Now you can compare the two results.
7
3
@Manzi @JayAr3 Why do you want to divide market cap by the number of outstanding shares? Then you just have the current stock price again. Just compare the market cap of Moderna against the market cap of Novavax and you see that Moderna is valued a lot higher.